Prestige Consumer Healthcare (PBH)$48.00
Currency: USD
Research Snapshot
Static fundamentals, valuation context, and investor signals for Prestige Consumer Healthcare (PBH).
DCF ready
Valuation
13.3x
EV/FCF, 7.5% FCF yield
Quality
6.6%
ROIC, 22.6% FCF margin
Growth
2.9%
5Y sales (revenue) CAGR
Balance sheet
0.5x
Debt/equity, 3.6x current ratio
Superinvestors
2
Top: John Rogers (2.8%)
Strengths to research
- Free cash flow margin is healthy at 22.6%.
- Debt/equity looks manageable at 0.5x.
- 10 annual periods are available for trend analysis.
Watchouts
No major valuation, balance sheet, or growth watchouts were detected by the static screen.
Annual data: 10 periods
Quarterly data: 24 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for PBH.
Grade D
42
/ 100
Financial Charts
No financial data available for PBH (annual).
2 superinvestors own PBH
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| John Rogers Ariel Appreciation Fund | 4,274,326 | $253M | 2.84% | 0.0% |
| Robert Olstein Olstein Capital Management | 21,000 | $1M | 0.27% | 0.0% |